The WT1 gene helps guide early kidney and reproductive organ development and controls how certain cells grow. If it does not work properly, a child may be more likely to develop Wilms tumor, kidney disease with protein leaking into the urine, or differences in sex development. In medicine, this gene is important because it helps regulate growth in tissues that form before birth. WT1 is best known in cancer and kidney genetics rather than through celebrity or news attention.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to make proteins, which are the working parts of cells. Others mainly direct when certain processes take place, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
WT1Gene function
What if the gene works
The WT1 gene helps guide early kidney, urinary tract, and reproductive organ development. It also supports specialized kidney cells that keep the body’s filters working and help stop protein from leaking into urine.
Risk
What if the gene does not work
Changes in the WT1 gene can affect kidney and reproductive development and may raise the chance of Wilms tumor. Effects range from milder to more severe variants, which can influence when problems appear and which features develop.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the WT1 gene can affect treatment when kidney disease is present, because it usually does not respond well to steroids or other immunosuppressive drugs. Care often focuses instead on supportive kidney treatment and planning for transplantation when needed. In some WT1-related sex development conditions, removal of very underdeveloped gonads may also be part of management.
Conditions associated with WT1
Gene function
What if the gene works
The WT1 gene helps guide how certain cells become working organs, especially before birth. It acts as a control switch for other genes, turning key instructions on at the right time. This is especially important for the kidneys and tissues involved in sex development. In adults, it also helps some kidney cells keep doing their daily work.
The WT1 gene helps switch many other genes on or off at the right time. This gives growing cells clear instructions for when to develop, mature, and keep their specialized role.
During early development, this gene helps guide normal kidney development before birth and supports parts of the reproductive system. It helps growing tissues follow the right timing and layout as organs take shape.
In the kidneys, the WT1 gene helps podocytes, the cells that wrap around tiny filters, stay stable and specialized. This supports the filtering barrier that keeps protein in the blood while waste passes into urine.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the WT1 gene can change how the WT1 protein folds, where it goes in the cell, or how well it binds DNA to control other genes. How WT1 gene variants affect protein function ranges from milder changes that alter isoforms to more severe variants that truncate the protein or disrupt its zinc finger binding region. This can reduce activity to varying degrees and, in conditions linked to WT1, may influence when kidney or sex development changes appear.
How variants are linked to conditions
Pathogenic variants in the WT1 gene can cause Wilms tumor predisposition, Denys-Drash syndrome, and Frasier syndrome. In many people, WT1 gene variants linked to conditions also involve nephrotic syndrome, chronic kidney disease, or differences in sex development. Certain acquired WT1 variants are also associated with some blood cancers, especially acute myeloid leukemia.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead reflect normal human diversity. In many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In contrast, in some situations, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For WT1, risk is driven mainly by the specific gene change rather than by lifestyle. Some WT1 changes carry a higher chance of kidney tumors or tumors in the gonads, and risk can also differ based on sex development and whether certain gonads are present. Regular monitoring helps find problems early.
Inheritance of WT1 variants
Variants in the WT1 gene are usually inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing WT1 gene variant can pass it to a child with a 50% chance in each pregnancy, whether the child is a son or a daughter. Some people with a WT1 inheritance pattern are the first in their family to have it because the variant arose new (de novo) and was not inherited from either parent. Once present, it can then be passed on to future children in the same autosomal dominant way.
What does my WT1 result mean for my family?
Many WT1-related conditions are passed down in a dominant way, so a parent, brother, sister, or child may also carry the same gene change and could consider genetic counseling or testing. A child of someone with a disease-causing WT1 variant may have a 1 in 2 chance of inheriting it. Some WT1 changes happen for the first time in one person, so a parent does not always carry the variant.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for WT1 variants usually uses a blood or saliva sample. A lab reads the DNA in the WT1 gene to look for variants that may help explain certain kidney findings, differences in sex development, or a family pattern of Wilms tumor, and results may show a pathogenic variant, no relevant variant, or an uncertain change.
When should I consider getting a genetic test?
Consider WT1 testing if there is a personal or family history of Wilms tumor, a childhood kidney cancer, certain kidney problems, or differences in sex development. It can also help when a child has kidney disease along with genital or urinary tract differences, because some WT1 changes confirm an inherited condition and guide checkups.
A genetic result is only one part of your health story
A genetic result can be informative, yet what it reveals depends on the condition and the specific type of variant involved. Many factors also influence how the body works over time, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to certain medicines. Small differences in genes can change how quickly a drug is processed, how strongly it works at its target, or how sensitive you are to side effects. This helps explain why the same treatment may work well for one person, work less well for another, or cause more unwanted effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way a person responds to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More information about this topic is available in the LearnHub.
Drugs influenced by the WT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
The WT1 gene entered medical history through studies of Wilms tumor, a childhood kidney cancer that helped researchers trace inherited cancer risk to a specific part of chromosome 11. In the late 1980s and early 1990s, scientists identified the WT1 gene as a major breakthrough in understanding why some children develop this cancer. Initially understood only through visible traits, later recognized as tied to a specific gene, WT1 also helped connect kidney tumors with certain differences present from birth. Its discovery strengthened the idea that changes in particular genes can drive both cancer and altered development. From these first observations, research expanded steadily. WT1 remains an important landmark in cancer genetics and pediatric medicine.